Latest Articles

Publication Date
A substantial step toward earlier endometrial cancer detection - Mayo Clinic

A substantial step toward earlier endometrial cancer detection Mayo Clinic

Published: Jan. 9, 2024, 8 a.m.
New drug offers promising breakthrough for endometriosis patients - The Telegraph

New drug offers promising breakthrough for endometriosis patients The Telegraph

Published: Jan. 9, 2024, 8 a.m.
When will women get real reproductive health care in America? - The Hill

When will women get real reproductive health care in America? The Hill

Published: Jan. 9, 2024, 8 a.m.
Life changing new treatment now offered at University Hospital Ayr - NHS Ayrshire & Arran

Life changing new treatment now offered at University Hospital Ayr NHS Ayrshire & Arran

Published: Jan. 9, 2024, 8 a.m.
From Lab to Market - news.uzh.ch

From Lab to Market news.uzh.ch

Published: Jan. 9, 2024, 8 a.m.
Sophie Kasaei Opens Up About Fertility Struggles: 'Trying for Months' with Boyfriend Jordan Brook - ABTC

Sophie Kasaei Opens Up About Fertility Struggles: 'Trying for Months' with Boyfriend Jordan Brook ABTC

Published: Jan. 9, 2024, 8 a.m.
SMYD3 promotes endometrial cancer through epigenetic regulation of LIG4/XRCC4/XLF complex in non-homologous end joining repair | Oncogenesis - Nature.com

SMYD3 promotes endometrial cancer through epigenetic regulation of LIG4/XRCC4/XLF complex in non-homologous end joining repair | Oncogenesis Nature.com

Published: Jan. 8, 2024, 8 a.m.
Michelle Ackerley discusses 'mental battle' amid struggle with endometriosis in early career - HELLO!

Michelle Ackerley discusses 'mental battle' amid struggle with endometriosis in early career HELLO!

Published: Jan. 8, 2024, 8 a.m.
Justyna Green's comic for period pants brand breaks an important taboo - Creative Boom

Justyna Green's comic for period pants brand breaks an important taboo Creative Boom

Published: Jan. 8, 2024, 8 a.m.
Aditxt, Inc.’s Subsidiary Pearsanta, Inc. Acquires MDNA Life Sciences Inc.’s Proprietary Mitomic™ Testing Platform Pioneering Early Disease and Cancer Detection in a Transaction Valued at Approximately $25 Million - Business Wire

Aditxt, Inc.’s Subsidiary Pearsanta, Inc. Acquires MDNA Life Sciences Inc.’s Proprietary Mitomic™ Testing Platform Pioneering Early Disease and Cancer Detection in a Transaction Valued at Approximately $25 Million Business Wire

Published: Jan. 8, 2024, 8 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!